Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Preterm Delivery: later-stage trial registry

1 of 5 indexed Preterm Delivery trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Preterm Delivery: 5 US clinical trials tracked, 1 recruiting.

Preterm Delivery is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Obstetrix Medical Group, running 1 of these trials.

Enrollment posture brief

Registry condition preterm-delivery

OPEN 1 | RECR 20% | LATE 2 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Preterm Delivery (this)20%
Open-enrollment share among volume-matched conditions near Preterm Delivery

Preterm Delivery lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Preterm Delivery on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Preterm Delivery is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Preterm Delivery research.

    Obstetrix Medical Group accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Preterm Delivery enrolment sits around 100 participants.

    Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Preterm Delivery splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Preterm Delivery records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

nurse case manager Behavioral
1 trials
Betamethasone or Dexamethasone (2nd course of ACS) Drug
1 trials
81mg Aspirin Drug
1 trials
162mg Aspirin Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Preterm Delivery trials. A trial with sites in several states counts in each.

Utah 2 trials
Colorado 2 trials
California 2 trials
Texas 1 trials
Tennessee 1 trials
Rhode Island 1 trials
Pennsylvania 1 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Preterm Delivery page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Preterm Delivery condition card totals 5 registered trials; most-linked intervention nurse case manager; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.